Trandolapril

CAS 87679-37-6 5 current records 6 historicalSmall Molecule

Who holds supplier records for Trandolapril? 5 organisations hold a current record for Trandolapril: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), USA (1) and Spain (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Trandolapril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/trandolapril

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Trandolapril. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Trandolapril sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Trandolapril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2007-184 - Rev 06
Trandolapril
Nov 2023—
ABBOTT LABORATORIES Abbott ParkUS
R1-CEP 2009-182 - Rev 01
Trandolapril
Mar 2020—
ROLABO OUTSOURCING, S.L. ZaragozaES
R1-CEP 2009-251 - Rev 01
Trandolapril
Dec 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Trandolapril are no longer active. These show a past filing, not current supply.

Show all 6 historical records

Overview

Trandolapril is an angiotensin-converting enzyme (ACE) inhibitor used in the treatment of hypertension and heart failure. It works by relaxing blood vessels, making it easier for the heart to pump blood.

Chemical identity

IUPAC name
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
Canonical SMILES
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O
InChIKey
VXFJYXUZANRPDJ-WTNASJBWSA-N
Synonyms
Mavik API, mavik, nsc-758939, ru 44570, ru-44570, tarka component trandolapril

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin Converting Enzyme Inhibitor
Mechanism of action
Angiotensin-converting Enzyme Inhibitors

Therapeutic areas

Cardiovascular SystemHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Trandolapril?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Trandolapril: APITORIA PHARMA PRIVATE LTD (India), ALIVUS LIFE SCIENCES LTD (India), Lupin Limited (India), Abbott Laboratories (USA) and ROLABO OUTSOURCING SL (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Trandolapril Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 19548), ALIVUS LIFE SCIENCES LTD (DMF 18165) and Lupin Limited (DMF 17658). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Trandolapril records mean?

6 organisations have only inactive Type II DMFs for Trandolapril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Trandolapril have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Trandolapril on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), ABBOTT LABORATORIES Abbott Park (US) and ROLABO OUTSOURCING, S.L. Zaragoza (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Trandolapril supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Trandolapril?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.